B vitamin supplementation improves cognitive function in the middle aged and elderly with hyperhomocysteinemia

References

• Ferri CP, Prince M, Brayne C, Brodaty H, Fratiglioni L, Ganguli M, Brodaty H, Fratiglioni L, Ganguli M, et al. Global prevalence of dementia: a Delphi consensus study. Lancet 2005;366:2112–7. doi: 10.1016/S0140-6736(05)67889-0
   PubMed Web of Science ®Google Scholar
• Seshadri S, Beiser A, Selhub J, Jacques PF, Rosenberg IH, D'Agostino RB, et al. Plasma homocysteine as a risk factor for dementia and Alzheimer's disease. N Engl J Med 2002;346:476–83. doi: 10.1056/NEJMoa011613
   PubMed Web of Science ®Google Scholar
• Koike T, Kuzuya M, Kanda S, Okada K, Izawa S, Enoki H, et al. Raised homocysteine and low folate and vitaminB-12 concentrations predict cognitive decline in community-dwelling older Japanese adults. Clin Nutr 2008;6:865–71. doi: 10.1016/j.clnu.2008.08.006
   Web of Science ®Google Scholar
• Haan MN, Miller JW, Aiello AE, Whitmer RA, Jagust WJ, Mungas DM, et al. Homocysteine, B vitamins, and the incidence of dementia and cognitive impairment: results from the Sacramento Area Latino Study on Aging. Am J Clin Nutr 2007;85:511–7.
   PubMed Web of Science ®Google Scholar
• Booth GL, Wang EE. Preventive health care, 2000 update: screening and management of hyperhomocysteinemia for the prevention of coronary artery disease events. The Canadian Task Force on Preventic Health Care. CMAJ 2000;11:21–9.
   Google Scholar
• Isotalo PA, Donnelly JG. Prevalence of methylenetetrahydrofolate reductase mutations in patients with venous thrombosis. Mol Diagn 2000;5:59–66. doi: 10.2165/00066982-200005010-00013
   PubMedGoogle Scholar
• Sunder PG, Fodinger M, Buchmayer H, Papagiannopoulos M, Wojcik J, Kletzmayr J, et al. Effect of high dose folic acid therapy on hyperhomocysteinemia in hemodialysis patients: results of the Vienna multicenter study. J Am Soc Nephrol 2000;11:1106–16.
   PubMed Web of Science ®Google Scholar
• Hai-yan K, Yu-gang J, Cheng-yu H, Heng-tong F, Jing L, Chang S, et al. Investigation of serum homocysteine level and cognitive function in the middle-aged and elderly lived in Tianjin. Hygiene Research 2008;6:668–70.
   Google Scholar
• Clarke R, Frost C, Sherliker P, Lewington S, Collins R, Brattstrom L, et al. Dose-dependent effects of folic acid on blood concentrations of homocysteine: a meta-analysis of the randomized trials. Am J Clin Nutr 2005;82:806–12.
   PubMed Web of Science ®Google Scholar
• Yajnik CS, Lubree HG, Thuse NV, Ramdas LV, Deshpande SS, Deshpande VU, et al. Oral vitamin B12 supplementation reduces plasma total homocysteine concentration in women in India. Asia Pac J Clin Nutr 2007;16:103–9.
   PubMed Web of Science ®Google Scholar
• Deshmukh US, Joglekar CV, Lubree HG, Ramdas LV, Bhat DS, Naik SS, et al. Effect of physiological doses of oral vitamin B12 on plasma homocysteine: a randomized, placebo-controlled, double-blind trial in India. Eur J Clin Nutr 2010;64:495–502. doi: 10.1038/ejcn.2010.15
   PubMed Web of Science ®Google Scholar
• Alvares Delfino VD, de Andrade Vianna AC, Mocelin AJ, Barbosa DS, Aiko Mise R, Matsuo T. Folic acid therapy reduces plasma homocysteine levels and improves plasma antioxidant capacity in hemodialysis patients.Nutr 2007;23:242–7.
   Google Scholar
• Schnyder G, Roffi M, Flammer Y, Pin R, Hess OM. The Swiss Heart Study: effect of homocysteine-lowering therapy with folic acid, vitamin B12, and vitamin B6 on clinical outcome after percutaneous coronary intervention: a randomized controlled trial. JAMA 2002;288:973–9. doi: 10.1001/jama.288.8.973
   PubMed Web of Science ®Google Scholar
• Schaumburg H, Kaplan J, Windebank A, Vick N, Rasmus S, Pleasure D, et al. Sensory neuropathy from pyridoxine abuse. N Engl J Med 1983;309:445–8. doi: 10.1056/NEJM198308253090801
   PubMed Web of Science ®Google Scholar
• de Jager CA, Oulhaj A, Jacoby R, Refsum H, Smith AD. Cognitive and clinical outcomes of homocysteine-lowering B-vitamin treatment in mild cognitive impairment: a randomized controlled trial. Int J Geriatric Psychiatry 2012;27:592–600. doi: 10.1002/gps.2758
   PubMed Web of Science ®Google Scholar
• Cotlarciuc I, Andrew T, Dew T, Clement G, Gill R, Surdulescu G, et al. The basis of differential responses to folic acid supplementation. J Nutrigenet Nutrigenomics 2011;4:99–109. doi: 10.1159/000327768
   PubMed Web of Science ®Google Scholar
• De Bree A, Verschuren WM, Kromhout D, Kluijtmans LAJ, Blom HJ, Kluijtmans LAJ, Blom HJ. Homocysteine determinants and the evidence to what extent homocysteine determines the risk of coronary heart disease. Pharmacol Rev 2002;54:599–618. doi: 10.1124/pr.54.4.599
   PubMed Web of Science ®Google Scholar
• Herrmann W, Herrmann M, Obeid R. Hyperhomocysteinaemia: a critical review of old and new aspects. Curr Drug Metab 2007;8:17–31. doi: 10.2174/138920007779315008
   PubMed Web of Science ®Google Scholar
• De-ming L, Chang L, Gui-yu L. The construction of ‘Basic Cognitive Capacity Test’ and its standardization. Acta Psychol Sinica 2001;33:453–60.
   Google Scholar
• McCaddon A, Hudson P, Davies G, Hughes A, Williams JH, Wilkinson C. Homocysteine and cognitive decline in healthy elderly dement. Geriatr Cogn Disord 2001;12:309–13. doi: 10.1159/000051275
   PubMed Web of Science ®Google Scholar
• Tucker KL, Qiao N, Scott T, Rosenberg I, Spiro A. High homocysteine and low B vitamins predict cognitive decline in aging men: the Veterans Affairs Normative Aging Study. Am J Clin Nutr 2005;82:627–35.
   PubMed Web of Science ®Google Scholar
• Folin M, Baiguera S, Gallucci M, Conconi MT, Liddo RD, Zanardo A, et al. A cross-sectional study of homocysteine, NO-level, CT-findings in Alzheimer dementia, vascular dementia and controls. Biogerontology 2005;4:255–60. doi: 10.1007/s10522-005-2622-3
   Web of Science ®Google Scholar
• Dao-mei C, Yu-gang J, Cheng-yu H, Hai-Yan K, Wei P, Hong-Peng Y. Polymorphism of MTHFR C677T, serum vitamin levels and cognition in subjects with hyperhomocysteinemia in China. Nutr Neurosci 2010;4:175–82.
   Google Scholar
• Jihye K, Moon HP, Eunkyung KCH, Han C, Jo SA, Jo I. Plasma homocysteine is associated with the risk of mild cognitive impairment in an elderly korean population. Am J Soci Nutr 2007;137:2093–7.
   PubMed Web of Science ®Google Scholar
• Ravaglia G, Forti P, Maioli F, Martelli M, Servadei L, Brunetti N, et al. Homocysteine and folate as risk factors for dementia and Alzheimer disease. Am J Clin Nutr 2005;82:636–43.
   PubMed Web of Science ®Google Scholar
• Van Guldener C, Gtehouwer CD. Homocysteine-lowering treatment: an overview. J Expert Opin Pyarmacother 2001;2:1449–60. doi: 10.1517/14656566.2.9.1449
   PubMedGoogle Scholar
• Chia S, Wilson R, Ludlam CA, Webb DJ, Flapan AD, Newby DE. Endothelial dysfunction in patients with recent myocardial infarction and hyperhomocysteinaemia: effects of vitamin supplementation. Clin Sci 2005;1:65–72. doi: 10.1042/CS20040150
   Google Scholar
• Clarke R, Harrison G, Richards S. Effect of vitamins and aspirin on markers of platelet activation, oxidative stress and homocysteine in people at high risk of dementia. J Intern Med 2003;254:67–75. doi: 10.1046/j.1365-2796.2003.01154.x
   PubMed Web of Science ®Google Scholar
• Lewerin C, Matousek M, Steen G, Johansson B, Steen B, Nilsson-Ehle H. Significant correlations of plasma homocysteine and serum methylmalonic acid with movement and cognitive performance in elderly subjects but no improvement from short-term vitamin therapy: a placebo-controlled randomized study. Am J Clin Nutr 2005;11:55–62.
   Google Scholar
• Hogervorst E, Ribeiro HM, Molyneux A, Budge M, Smith AD. Plasma homocysteine levels, cerebrovascular risk factors, and cerebral white matter changes (leukoaraiosis) in patients with Alzheimer 's disease. Arch Neurol 2002;5:787–93. doi: 10.1001/archneur.59.5.787
   Google Scholar
• Sachdev PS, Valenzuela M, Wang XL, Looi JCL, Brodaty H. Relationship between plasma homocysteine levels and brain atrophy in healthy elderly individuals. Neurology 2002;10:1539–41. doi: 10.1212/WNL.58.10.1539
   Google Scholar